Publications by authors named "M Joloba"

Killer-cell immunoglobulin-like receptors (s) are essential components of the innate immune system found on the surfaces of natural killer (NK) cells. The s encoding genes are located on chromosome 19q13.4 and are genetically diverse across populations.

View Article and Find Full Text PDF

Background: Rapid diagnosis of tuberculosis (TB) is important for improving outcomes and reducing transmission. Previous studies assessing the impact of Xpert MTB/RIF (Xpert), a molecular assay that provides results within 2 h, on mortality have been inconclusive. In this planned analysis of a pragmatic cluster-randomized trial in Uganda, we assessed whether a multicomponent strategy, including decentralized Xpert testing, decreased mortality among adults evaluated for TB.

View Article and Find Full Text PDF

In 2014, the World Health Organisation (WHO) published target product profiles (TPP) for development of novel tuberculosis (TB) diagnostics. One of the key highlights is the need for point-of-care non-sputum-based tests capable of detecting all forms of TB through identification of characteristic biomarkers or biosignatures. Compared to the limitations associated with sputum-based TB tests, non-sputum samples are easy to collect, non-invasive, with potential to improve TB diagnosis among children and among people living with HIV/AIDS (PLHIV).

View Article and Find Full Text PDF
Article Synopsis
  • The study focused on understanding the distribution of extended-spectrum β-lactamase-producing Escherichia coli (ESBL-Ec) in patients and their hospital environment to improve infection prevention strategies.
  • Researchers collected rectal swabs from patients and swabs from the hospital environment, identifying 209 ESBL isolates, with 15 being ESBL-Ec originating from both patients (53.3%) and the environment (46.7%).
  • The findings revealed diverse strains of ESBL-Ec with multiple drug resistance genes and plasmids, indicating a need for routine screening upon patient admission to prevent infections.
View Article and Find Full Text PDF
Article Synopsis
  • Hematological cancers like Leukemias and Lymphomas can weaken immune responses, increasing the risk of infections including Human cytomegalovirus (HCMV), particularly in febrile patients.
  • A study at the Uganda Cancer Institute found that 66% of 161 febrile hematological cancer patients had been exposed to HCMV, with 14.3% showing signs of active infection.
  • The findings suggest that routine HCMV testing in these patients is crucial for timely antiviral treatment to manage infections effectively.
View Article and Find Full Text PDF